Enjoy complimentary customisation on priority with our Enterprise License!
The electroencephalogram (EEG) and electromyography (EMG) devices market is forecast to increase by USD 826.8 million and is estimated to grow at a CAGR of 8.59% between 2022 and 2027. The market is experiencing significant expansion due to several key factors. Firstly, the rising incidence of neurological disorders is driving demand for diagnostic and therapeutic interventions, making EEG and EMG procedures increasingly essential. Secondly, the growing awareness of the benefits of early diagnosis and intervention in neurological conditions is fueling the demand for these devices. Additionally, governments and healthcare organizations are investing in research and development initiatives to advance the technology and make it more accessible to patients. The growing acceptance of telemedicine and remote patient monitoring is also contributing to the market growth, enabling easier access to these procedures from the comfort of one's home. Overall, the combination of these factors is creating a favorable environment for the growth of the market.
To learn more about this report, Download Report Sample
The market plays a crucial role in diagnosing and monitoring various neurological and muscular conditions. EEG equipment, along with analog to digital converters and computer software, captures and analyzes electrical impulses in the brain, aiding in the diagnosis of disorders such as epilepsy, migraines, and Alzheimer's disease. Cloud devices facilitate real-time review and daily reporting, enhancing diagnostic procedures and patient care. On the other hand, EMG equipment, including signal amplifiers and recorders, assesses muscle activity, vital for detecting disorders like Parkinson's disease and multiple sclerosis. Advancements in technology have led to the development of wearable home monitoring systems with flexible non-invasive electrodes, ensuring mobility and comfort for patients while offering accurate data capture. However, challenges persist, including the low spatial resolution of EEG equipment and accuracy concerns with EMG equipment. Disturbances from surroundings and rigid headbands can impact readings, highlighting the need for continuous innovation in device design and software development. As the demand for non-invasive diagnostic tools grows, the market continues to evolve, driven by advancements in sensor technology and the growing prevalence of neurological and muscular disorders among pediatric and geriatric populations. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing prevalence of neurological conditions is the key factor driving the market. The increasing prevalence of neurological diseases increases the demand for brain monitoring devices such as EEG, which are widely used in the diagnosis of such diseases. EEG helps doctors detect neurological disorders at an early stage, understand the severity of the disorder and monitor brain activity to better understand the disease and its effects on brain regions.
The prevalence of neuromuscular disorders such as muscular dystrophy, peripheral neuropathy, spinal muscular atrophy, and amyotrophic lateral sclerosis is also increasing. Moreover, the high prevalence of neuromuscular disorders will raise the demand for EMG devices in the UK, which measure the electrical activity in muscles and nerves to diagnose neuromuscular disorders. Thus, the growing prevalence of neurological conditions will increase the demand for EEG and EMG devices, which will drive the growth of the global market during the forecast period.
The increasing popularity of hybrid brain-computer interface techniques is the primary trend in the market. The demand for equipment combining two or more modalities in brain imaging and prosthesis control is increasing. Hybrid brain-computer interface (hBCI) has many benefits over single brain acquisition modalities. The hBCI also provides more reliable information for control and rehabilitation applications than a single modality brain-computer interface. EEG, owing to its easy use and fast temporal resolution, is being widely used with other brain/non-brain signal acquisition modalities.
Moreover, the advantages of hBCI over single modality brain-computer interface, they are gaining more popularity in the global market. Hence, such factors are expected to fuel the growth of the global market during the forecast period.
High costs associated with EEG and EMG procedures are a major challenge to the market. The lack of skilled and trained professionals in the healthcare system, especially in developing countries such as India, Iran, Bangladesh, and several others, is a major factor limiting the growth of the global market. The accuracy and reliability of EEG and EMG tests depend on the skills of the doctors performing the examination. High-quality and reproducible EEG and EMG tests depend on how doctors physically position, transmit and record electrical signals with a needle electrode, approach clinical problems, and analyze the electrical signal recorded by the muscle using auditory pattern recognition.
Unlike other tests that use data-producing devices, the correct performance and interpretation of EEG and EMG depend on the experience of the physicians in neuromuscular medicine. Hence, the dearth of skilled and trained professionals, the presence of poor healthcare infrastructure, and the adoption of substitute products for neurodiagnostic will impede the growth of the global market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
advancedbrainmonitoring.com - The company offers EEG and EMG devices such as Neuroplot and Virgo.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the EEG Devices segment will be significant during the forecast period. The EEG devices segment accounts for the largest share of the global market. The growth of this segment can be attributed to factors such as the increasing prevalence of neurological diseases, new product launches, and the growing investments by market players in developing new wireless and portable EEG devices.
Get a glance at the market contribution of various segments Request a PDF Sample
The EEG Devices segment was valued at USD 778.50 million in 2017 and continue to grow by 2021. Technological advances have led to the miniaturization of electronics, including the development of portable EEG devices. The demand for such portable EEG devices is increasing in-home care and outpatient settings. Portable EEG devices include ambulatory EEG and wearable EEG devices, which are lightweight, small, and handy and can be set up quickly. They facilitate real-time neuroimaging. Hence, they are easy to use in outpatient and home care settings. Various new vendors are entering the market with their innovative wireless and portable EEG offerings. Such technological advances in products through the development of wireless and portable EEG devices and the growing demand for portable EEG devices will increase the adoption of EEG devices in home care settings and among outpatients, which will boost the growth of the EEG devices segment during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The increasing prevalence of neurological conditions, including neuromuscular disorders, is likely to augment the demand for EEG and EMG devices in North America. Every year, about 150,000 Americans are diagnosed with these central nervous system disorders, which cause seizures. As EEG is primarily used in monitoring seizures in patients, the growing prevalence of epilepsy in the region is likely to drive the growth of the market in North America during the forecast period.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2023 to 2027, as well as historical data from 2017 to 2021 for the following segments
You may also interested in below market reports:
The market is pivotal in diagnosing neurological disorders worldwide, offering insights into the electrical activity of the brain and skeletal muscles. EEG equipment, comprising electrodes, amplifiers, and filters, monitors brain wave patterns, aiding in the detection of conditions like strokes, brain tumors, and sleeping disorders. EMG equipment, with cables, signal amplifiers, and speakers, assesses muscle function, crucial in diagnosing conditions such as muscular dystrophy and myasthenia gravis. Advancements in technology have led to portable EEG machines and wearable devices, enhancing mobility and comfort for patients while enabling minimally invasive procedures. Future wearable EEG devices promise even greater accessibility and convenience, with features like automatic data backfill and real-time review.
However, challenges persist, including poor spatial resolution and sampling errors in EEG equipment, and accuracy concerns with EMG equipment. Disturbances from surroundings and surface electrodes further complicate readings. Despite these challenges, the market continues to evolve, with a focus on preventive care and home monitoring systems. The market landscape depends on the Cloud device, Motor neurons, Brain damage, Encephalopathy, Sleep disorders, EEG data capture, Real time review, Complete data set, Brainwave monitoring devices, Lower risk of complications. Flexible headbands, like the Dreem headband (DH), offer comfortable options for long-term monitoring, while neurophysiology equipment, such as EEG dry electrodes, addresses concerns of mild cognitive impairment and subjective cognitive decline. As demand grows for non-invasive and accurate diagnostic tools, the market remains integral to understanding brain function, cognition, and sensory processing.
Market Scope |
|
Report Coverage |
Details |
Page number |
159 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.59% |
Market growth 2023-2027 |
USD 826.8 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.81 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 40% |
Key countries |
US, Germany, France, UK, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advanced Brain Monitoring Inc., Allengers Medical Systems Ltd., Ambu AS, Bio Signal Group Corp., BioSerenity, Brain Scientific Inc., BrainScope Co. Inc., Cadwell Industries Inc., Ceribell Inc., Compumedics Ltd., Contec Medical Systems Co. Ltd., DEYMED Diagnostic sro, General Electric Co., iMediSync Inc., Koninklijke Philips NV, Masimo Corp., mBrainTrain LLC, Medtronic Plc, Micromed SpA, Natus Medical Inc., NeuroWave Systems Inc., Nihon Kohden Corp., Noraxon USA Inc., and Zeto Inc. |
Market dynamics |
Parent market analysis, market growth analysis, market research and growth, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Modality
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.